Intercell's P2P Acquisition

Intercell raised a round of funding on May 29, 2013. Investors include Valneva.

Intercell AG, (formerly Iomai Corp.) has developed a method to safely and more effectively deliver vaccines through the use of a skin patch and without any injections.…

Articles about Intercell's P2P Acquisition: